| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.307 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.307 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.307 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.307 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.307 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.307 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.307 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.307 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.307 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.307 |
Evidence |
|
| OXTR |
OXTR: Oxytocin receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.307 |
Evidence |
|
| OXTR |
OXTR: Oxytocin receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
GNAI2 |
Galphai2 protein |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.307 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.307 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.307 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.307 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.307 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
0.307 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| CST5 |
CST5: Cystatin-D precursor |
CTSZ |
CTSZ: Cathepsin Z precursor |
0.307 |
Evidence |
|